American Society of Gene & Cell Therapy – 2020 Policy Summit

Loading Events

The mission of the American Society of Gene & Cell Therapy (ASGCT) is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. ASGCT’s strategic vision is to be a catalyst for bringing together scientists, physicians, patient advocates, and other stakeholders to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.

Attend the ASGCT 2020 Policy Summit that will address payment policy, and global regulatory and ethical issues around the delivery of cell and gene therapies.

Mogrify has developed a proprietary direct cellular conversion technology, which makes it possible to enhance existing stem-cell forward reprogramming methods or bypass development pathways altogether, effecting a direct transdifferentiation between a mature cell type to another mature cell type.

Go to Top